Stephen Harris

Title: The Innovative Contributions of Stephen Harris

Introduction

Stephen Harris is a notable inventor based in Stamford, CT (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of intranasal dosage forms. With a total of 3 patents to his name, Harris has focused on addressing critical health issues, such as opioid overdosing.

Latest Patents

Harris's latest patents include an innovative intranasal pharmaceutical dosage form comprising naloxone. This invention features a dosing unit that includes naloxone or a pharmaceutically acceptable salt thereof, with an amount equivalent to ≥0.5 mg naloxone HCl dissolved in an application fluid of a volume of ≤250 μl. This formulation is specifically designed for use in the treatment of opioid overdosing and/or at least one symptom thereof. The significance of this invention lies in its potential to provide rapid intervention in life-threatening situations.

Career Highlights

Throughout his career, Stephen Harris has worked with various organizations, including Harm Reduction Therapeutics, Inc. and Euro-Celtique S.A. His experience in these companies has allowed him to refine his expertise in pharmaceutical innovations and contribute to the development of life-saving treatments.

Collaborations

Harris has collaborated with notable professionals in the field, including John Strang and Alexander Oksche. These partnerships have further enhanced his work and expanded the impact of his inventions.

Conclusion

Stephen Harris is a dedicated inventor whose work in developing intranasal pharmaceutical dosage forms has the potential to save lives. His innovative approach to addressing opioid overdosing showcases the importance of research and development in the pharmaceutical industry.